These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7475728)
21. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875 [TBL] [Abstract][Full Text] [Related]
22. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer. Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960 [TBL] [Abstract][Full Text] [Related]
23. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
24. Tamoxifen and the uterus: an old drug tested by new modalities. Achiron R; Grisaru D; Golan-Porat N; Lipitz S Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108 [TBL] [Abstract][Full Text] [Related]
25. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
26. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
27. Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy. Kieback DG; Harbeck N; Bauer W; Hadji P; Weyer G; Menschik T; Hasenburg A Gynecol Oncol; 2010 Dec; 119(3):500-5. PubMed ID: 20832103 [TBL] [Abstract][Full Text] [Related]
28. Endometrial thickness of postmenopausal breast cancer patients treated with tamoxifen. Salazar EL; Paredes A; Calzada L Gynecol Endocrinol; 2005 Dec; 21(6):312-6. PubMed ID: 16390778 [TBL] [Abstract][Full Text] [Related]
29. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
30. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen. Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378 [TBL] [Abstract][Full Text] [Related]
31. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen. Gao WL; Zhang LP; Feng LM Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565 [TBL] [Abstract][Full Text] [Related]
32. Endometrial tubal metaplasia in a young puerperal woman after breast cancer. Di Benedetto L; Giovanale V; Caserta D Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678 [TBL] [Abstract][Full Text] [Related]
33. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946 [TBL] [Abstract][Full Text] [Related]
34. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors. Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259 [TBL] [Abstract][Full Text] [Related]
35. Endometrial evaluation is a very important tool in the management of breast cancer patients. Berlière M; Galant C; Charles A; Brichard V; Piette P; Donnez J Eur J Cancer; 2002 Nov; 38 Suppl 6():S67-8. PubMed ID: 12409081 [No Abstract] [Full Text] [Related]
36. [Endometrial ablation versus hysterectomy in women treated with tamoxifen]. Capuano I; Caporale A; Vagnetti P; Di Domenico A; Felicetti M; Torella M; Borrelli AL Minerva Ginecol; 2007 Oct; 59(5):499-504. PubMed ID: 17912176 [TBL] [Abstract][Full Text] [Related]
37. Hysteroscopic follow-up during tamoxifen treatment. Neven P; De Muylder X; Van Belle Y; Vanderick G; De Muylder E Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):235-8. PubMed ID: 2335258 [TBL] [Abstract][Full Text] [Related]
38. [Follow up examination of the endometrium during tamoxifen therapy]. Major T; Bacskó G; Fülöp B; Juhász B; Jakab A Orv Hetil; 1998 Jan; 139(3):121-4. PubMed ID: 9467294 [TBL] [Abstract][Full Text] [Related]
39. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen. Zhu Y; Yang J J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697 [TBL] [Abstract][Full Text] [Related]
40. Progestins and the endometrium in patients receiving tamoxifen. Bertelli G; Venturini M; Bergaglio M; Gustavino C; Rosso R; Valenzano M Br J Cancer; 1999 Jun; 80(7):1114. PubMed ID: 10362126 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]